Clarithromycin resistance prevalence and Icea gene status in Helicobacter pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia

Journal of Microbiology

Volumn 44, Issue 4, 2006, Pages 409-416

  Baglan, Peren H ^a   Bozdayi, Gulendam ^b   Ozkan, Muhip ^a   Ahmed, Kamruddin ^c,d   Bozdayi, A Mithat ^a   Ozden, Ali ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c BILKENT UNIVERSITY   (Turkey)

^d NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

23S rRNA; Clarithromycin resistance; Helicobacter pylori; iceA

Indexed keywords

HELICOBACTER PYLORI;

ANTIINFECTIVE AGENT; CLARITHROMYCIN; ICE NUCLEATION PROTEIN; OUTER MEMBRANE PROTEIN; RIBOSOME DNA;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; DUODENUM ULCER; DYSPEPSIA; FEMALE; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CLARITHROMYCIN; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; DUODENAL ULCER; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TURKEY;

EID: 33750584840     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Alarcon, T., D. Domingo, and M. Lopez-Brea. 1999. Antibiotic resistance problems with Helicobacter pylori. Inter. J. Antimicro. Agents 1, 19-26.
2. Ashour, A.A., G.B. Collares, E.N. Mendes, V.R. Gusmao, D.M. Queiroz, P.P. Magalhaes, A.S. de Carvalho, C.A. de Oliveira, A.M. Nogueira, G.A. Rocha, and A.M. Rocha. 2001. IceA genotypes of Helicobacter pylori strains isolated from Brazilian children and adults. J. Clin. Microbiol. 39, 1746-1750.
3. Bayerdorffer, E., A. Neubauer, B. Rudolph, C. Thiede, N. Lehn, S. Eidt, and M. Stolte. 1995. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345, 1591-1594.
4. Broutet, N., S. Tchamgoue, E. Pereira, H. Lamouliatte, R. Salamon, and F. Megraud. 2003. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment. Pharmacol. Ther. 17, 99-109.
5. Damaso, D., T. Alarcon, N. Prieto, and M. Lopez-Brea. 1999. Relationship between antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. Rev. Esp. Quimioter. 12, 340-345.
6. Dubois, A., D.E. Berg, E.T. Incecik, N. Fiala, A.L. Heman, P.G. Perez, and M.J. Blaser. 1996. Transient and persistent experimental infection of non-human primates with Helicobacter pylori: implications for human disease. Infect. Immun. 64, 2885-2891.
7. Dzierzanowska-Fangrat, K., E. Rozynek, P. Jozwiak, D. Celinska-Cedro, K. Madalinski, and D. Dzierzanowska. 2001. Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland. In.t J. Antimicrob. Agents 18, 387-390.
8. Ende, A, L.J. Doorn, S. Rooijakkers, M. Feller, G.N.J. Tytgat, and J. Dankert. 2001. Clarithromycin- susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastic biopsy specimens prior to antibiotic therapy. J. Clin. Microbiol. 39, 2648-2651.
9. Eun, C.S., D.S. Han, J.Y. Park, Y.C. Jeon, J.S. Hahm, K.S. Kim, and J.O. Kang. 2003. Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases. Gastroenterol. 38, 436-441.
10. Fallone, C.A. 2000. Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. Can. J. Gastroenterol. 14, 879-882.
11. Figueiredo, C., L.J. van Doorn, C. Nogueira, J.M. Soares, C. Pinho, P. Figueira, W.G. Quint, and F. Carneiro. 2001. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand. J. Gastroenterol. 36, 128-135.
12. Fontana, C., M. Favaro, S. Minelli, A.A. Criscuolo, A. Peitro Yusti, A. Galante, and C. Favalli. 2002. New site of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicro. Agents Chemother. 46, 3765-3769.
13. Fraser, A.G., L. Moore, M. Hackett, and B. Hollis. 1999. Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit. Aust. N. Z. J. Med. 29, 512-516.
14. Glupczynski, Y., F. Megraud, M. Lopez-Brea, and L.P. Andersen. 2001. European multicenter survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 11, 820-823.
15. Godoy, A.P.O., M.L. Ribeiro, Y.H.B. Benvengo, L. Vitiello, M.C.B. Miranda, S. Mendonca, and J. Pedrazolli, Jr. 2003. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenter. 3, 20-26.
16. Goldman, R.C., D. Zakula, R. Flamm, I. Beyer, and I. Capobianco. 1994. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob. Agents Chemother. 38, 1496-1500.
17. Graham, D.Y., G.M. Lew, P.D. Klein, D.G. Evans, D.J. Evans, Jr., Z.A. Saeed, and H.M. Malaty. 1992. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann. Intern. Med. 116, 705-708.
18. Guliter, S., H. Keles, Z.N. Ozkurt, D.U. Cengiz, and E. Kolukisa. 2005. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of Helicobacter pylori? Turk. J. Gastroenterol. 16, 29-33.
19. Han, Y.H, W.Z. Liu, H.Y. Zhu, and S.D. Xiao. 2004. Clinical relevance of iceA and babA2 genotypes of Helicobacter pylori in a Shanghai population. Chin. J. Dig. Dis. 5, 181-185
20. Hirschl, A.M., M. Richter, A. Makristathis, P.M. Pruckl, B. Willinger, K. Schutze, and M.L. Rotter. 1994. Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: Detection by macrorestriction DNA analysis. J. Inf. Dis. 170, 829-33.
21. Inan, A., S. Gulsun, H. Guveli, J. Tascioǧlu, and P. Goktas. 2005. An investigation of Helicobacter pylori using culture, histopathological and serological examination methods and its antimicrobial sensitivities. Saudi. Med. J. 26, 597-600.
22. Jorgensen, M., G. Daskalopoulus, V. Warburton, H.M. Mitchell, and S.L. Hazell. 1996. Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential and multiple biopsy specimens. J. Infect. Dis. 174, 631-635.
23. Kato, M., Y. Yamaoka, J.J. Kim, R. Reddy, M. Asaka, K. Kashima, M.S. Osato, F.A. El-Zaatari, D.Y. Graham, and D.H. Kwon. 2000. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob. Agents Chemother. 44, 2214-2216.
24. Khan, R., S. Nahar, J. Sultana, M.M. Ahmad, and R. Motiur. 2004. T2182C Mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob. Agents Chemother. 48, 3567-3569.
25. Kidd, M., R.M. Peek, A.J. Lastovica, D.A. Israel, A.F. Kummer, and J.A. Louw. 2001. Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease. Gut 49, 629-635.
26. Kim, J.J., R. Reddy, M. Lee, J.G. Kim, F.A. El-Zaatari, M.S. Osato, D.Y. Graham, and D.H. Kwon. 2001. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J. Antimicrob. Chemother. 47, 459-461.
27. Laine, L., M.B. Fennerty, M. Osato, J. Sugg, L. Suchower, P. Probst, and J.G. Levine. 2000. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicentre, double-blind trials. Am. J. Gastroenterol. 95, 3393-3398.
28. Laine, L., R. Hunt, H. El-Zimaity, B. Nguyen, M. Osato, and J. Spenard. 2003. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicentre, North American trial. Am. J. Gastroenterol. 98, 562-567.
29. Lee, A. and F. Megraud. 1996. Helicobacter pylori: Techniques for clinical diagnosis and basic research, p. 122-123. In J. Hua, C. Birac, and F. Megraud. PCR-based RAPD 'fingerprinting' of clinical isolates of Helicobacter pylori, 2nd ed. Saunders Company Ltd, London, UK
30. Ling, T.K.W., W.K. Leung, C.C. Lee, E.K. Ng, M.Y. Yung, M.Y. Chung, S.S. Chung, J.J. Sung, and A.F. Cheng. 2002. The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001). Helicobacter 7, 327-329.
31. Loivukene, K., H. Kolk, H.I. Maaroos, P. Kasenomm, M. Ustav, and M. Mikelsaar. 2000. Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia. Scand. J. Infect. Dis. 32, 59-62.
32. Lui, S.Y., K.G. Yeoh, and B. Ho. 2003. Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population. J. Clin. Microbiol. 41, 5011-5014.
33. Marshall, B.J. 1994. Helicobacter pylori. Am. J. Gastroenterol. 89, 116-118.
34. Megraud, F., C. Camou-Juncas, A. Occhialini, and C. Birac. 1996. Helicobacter pylori resistance levels to clarithromycin remain stable. Gastroenterology 100, A192.
35. Megraud, F. 2003. Surveillance de la résistance de Helicobacter pylori aux antibiotiques, p. 327-329. In Surveillance nationale des maladies infectieuses, 1998-2000. Institut de Veille Sanitaire, St. Maurice, France
36. Megraud, F. 2004. Helicobacter pylori resistance: prevalence importance and advances in testing. Gut 53, 1374-1384.
37. Mohammadi, M., D. Doroud, S. Massarrat, and M.J. Farahvash. 2003. Clarithromycin resistance in Iranian H. pylori strains before introduction of clarithromycin. Helicobacter 8, 79-80.
38. National Committee for Laboratory Standards. Performance standards for antimicrobial testing. 1999. VI th International supplement. M100S9. National Committee for Clinical Laboratory Standards, Villanova, PA, USA
39. NIH. 1994. Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. J. Am. Med. Assn. 272, 65-69.
40. Nishiya, D., T. Shimoyama, S. Fukuda, T. Yoshimura, M. Tanaka, and A. Munakata. 2000. Evaluation of the clinical relevance of the iceA1 gene in patients with Helicobacter pylori infection in Japan. Scand. J. Gastroenterol. 35, 36-39.
41. Nomura, A., G.N. Stemmarman, and P.H. Chyou. 1994. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann. Intern. Med. 120, 977-981.
42. Osato, M.S., R. Reddy, S.G. Reddy, R.L. Penland, H.M. Malaty, and D.Y. Graham. 2001. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch. Intern. Med. 161, 1217-1220.
43. Palabiyikoglu, M., F. Sahin, A. Ozden, and O. Uzunalimoglu. 1997. Determination of primary resistance in Helicobacter pylori isolates to clarithromycin and amoxycilline by disc diffusion method and the comparison with resistance in recurrent cases. Turk. J. Gastroenterol. 8, 309-312.
44. Peek, R.M. Jr, S.A. Thompson, J.P. Donahue, K.T. Tham, J.C. Atherton, M.J. Blaser, and G.G. Miller. 1998. Adherance to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc. Assoc. Am. Physicians. 110, 531-544.
45. Perez Aldana, L., M. Kato, S. Nakagawa, M. Kawarasaki, T. Nagasako, T. Mizushima, H. Oda, J. Kodaira, Y. Shimizu, Y. Komatsu, R. Zheng, H. Takeda, T. Sugiyama, and M. Asaka. 2002. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 7, 306-309.
46. Perng, C.L., H.J. Lin, W.C. Lo, G.Y. Tseng, I.C. Sun, and Y.H. Ou. 2004. Genotypes of Helicobacter pylori in patients with peptic ulcer bleeding. World J. Gastroenterol. 10, 602-605.
47. Pounder, R.E. 1997. New developments in Helicobacter pylori eradication therapy. Scand. J. Gastroenterol. Suppl. 223, 43-45.
48. Ribeiro, M.L., L. Vitiello, M.C.B. Miranda, Y.H.B. Benvengo, A.P.O. Godoy, S. Mendonca, and J. Pedrazolli, Jr. 2003. Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil. Annal. Clinic. Microbiol. Antimicrob. 2, 1-15.
49. Sahin, F., A. Ozden, E. Unver, H. Ozenci, O. Uzunalimoglu, G. Atalay, and O. Koc. 1994. Detecting the resistance by agar dilution method for metronidazole and disc diffusion method for amoxycilline and clarithromycin in Helicobacter pylori isolates. Gastroenterology 5, 203-206.
50. Sarma, Z., H. Shmuely, Y. Niv, G. Dinari, D.J. Passaro, A. Geler, E. Gal, M. Fishman, J. Bachor, and J. Yahav. 2002. Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J. Antimicrob. Chemother. 49, 1023-1026.
51. Sevin, E., D. Lamarque, J.C. Delchier, C.J. Soussy, and J. Tankovic. 1998. Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR. FEMS Microbiol. Letters 165, 369-372.
52. Simsek, H., Y.H. Balaban, D.D. Gunes, G. Hascelik, E. Ozarslan, and G. Tatar. 2005. Alarming Clarithromycin Resistance of Helicobacter pylori in Turkish Population. Helicobacter 10, 360-361.
53. Sipponen, P. 1991. Helicobacter pylori and chronic gastritis: an increased risk of peptic ulcer? Scand. J. Gastroenterol. 26, 6-10.
54. Solerman, A., A. Perren, S. Schmid, F. Eigenmann, R. Guller, K.B. Weher, F. Meier, P. Eichenberger, and P. Komminoth. 2005. Assesment of Helicobacter pylori clarihromycin resistance mutations in archival gastric biopsy samples. Swiss. Med. Wkly. 135, 327-332.
55. Soltesz, V., B. Zeeberg, and T. Wadstrom. 1992. Optimal survival of Helicobacter pylori under various transport conditions. J. Clin. Microbiol. 30, 1453-1456.
56. Taylor, D.E., Z. Ge, D. Purych, T. Lo, and K. Hiratsuka. 1997. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents. Chemother. 41, 2621-2628.
57. Teo, E.K., Fock K.M., T.M. Ng, C.J. Khor, and A.L. Tan. 2000. Metronidazole-resistant Helicobacter pylori in an urban Asian population. J. Gastroenterol. Hepatol. 15, 494-497.
58. Toracchio, S., G.M. Aceto, R. Mariani-Costantini, P. Battista, and L. Marzio. 2004. Identification of a Novel Mutation Affecting Domain V of the 23S rRNA Gene in Helicobacter pylori. Helicobacter 9, 396-399.
59. Uemura, N., S. Okamoto, S. Yamamamoto, N. Matsumura, S. Yamaguchi, M. Yamakido, K. Taniyama, N. Sasaki, and R.J. Schlemper. 2001. Helicobacter pylori infection and the development of gastric cancers. N. England. J. Med. 345, 784-789.
60. Van Doorn, L.J., C. Figueiredo, R. Sanna, A. Plaisier, P. Schneeberger, W. de Boer, and W. Quint. 1998. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115, 58-66.
61. Van Doorn, L.J., C. Figueiredo, R. Rossau, G. Jannes, M. van Asbroek, J.C. Sousa, F. Carneiro, W.G. Quint. 1998. Typing of Helicobacter pylori vacA gene, and detection of cagA gene by PCR, and reverse hybridization. J. Clin. Microbiol. 36, 1271-1276.
62. Van Doorn, L.J., J. Yvette, Y.J. Debets-Ossenkopp, A. Marais, R. Sana, F. Megraud, J.G. Kusters, and W.G.V. Quint. 1999. Rapid detection, by PCR and Reverse Hybridization of Mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob. Agent. Chemother. 43, 1779-1782.
63. Van Doorn, L.J., Y. Glupczynski, J.G. Kusters, R. Megraud, P. Midolo, N. Maggi-Soloca, D.M.M. Quiroz, N. Nouhan, E. Stet, and W.G.V. Quint. 2001. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line prob assay for detection of mutations in the 23S rRNA Gene: Multicenter validation study. Antimicrob. Agent. Chemother. 45, 1500-1504.
64. Versalovic, J., D. Shortridge, K. Kibler, M.V. Griffy, J. Beyer, R.K. Flamm, S.K. Tanaka, D.Y. Graham, and M.F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents. Chemother. 40, 477-480.
65. World Health Organization. 1994. IARC monographs on the evaluation of carcinogenic risks to human, Geneva. World Health Organization 61, 177-240.
66. Wu, C.C., P.Y. Chou, C.T. Hu, Z.C. Liu, C.Y. Lin, Y.H. Tseng, and N.T. Lin. 2005. Clinical Relevance of the vacA, iceA, cagA, and flaA genes of Helicobacter pylori strains isolated in Eastern Taiwan. J. Clin. Microbiol. 43, 2913-2915.
67. Yamaoka, Y., T. Kodama, O. Gutierrez, J.G. Kim, K. Kashima, and D.Y. Graham. 1999. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 37, 2274-2279.